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Abstract
Dengue infection can produce a wide clinical spec-
trum of inflammatory manifestations in the eye. 
Ocular manifestations during the critical period 
of the disease are more frequently associated with 
vascular damage induced by the viral protein NS1. 
Sight-threatening retinal conditions in that period 
include posterior uveitis and dengue maculopathy. 
Retinal hemorrhages, edema, vasculitis and exuda-
tive retinal detachment are the most frequent pre-
sentations of posterior uveitis. SD-OCT and OCTA 
are tools capable to locate the affected retinal layers 
and capillary plexus involved in the retinopathy. Al-
though infrequent, neuroophthalmological manifes-
tations are an important cause of visual disturbance, 
inducing ophthalmological inter-consults in hospital-
ized patients. Available treatments include supportive 
measures, systemic corticosteroids and intravenous 
immunoglobulin. There is an urgent need for clinical 
studies to test drugs known to restore vascular per-
meability as well as new antiviral drug candidates.
Keywords: dengue, ocular manifestations, 2020 ep-
idemic.
Manifestaciones inflamatorias oculares 
inducidas por el virus del dengue
Resumen
La infección por dengue produce un amplio espec-
tro de manifestaciones inflamatorias oculares. Las 
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que ocurren durante el período crítico de la enfer-
medad están asociadas con daño vascular induci-
do por la proteína viral NS1. Las manifestaciones 
retinales que pone en riesgo la visión del paciente 
durante este período son las uveítis posteriores y 
la maculopatía por dengue. Hemorragias, edema 
y vasculitis retinal junto con el desprendimiento 
exudativo de retina son las manifestaciones ocu-
lares más frecuentes de la uveítis posterior. La 
tomografía de coherencia óptica de dominio es-
pectral (SD-OCT) y la angiografía tomográfica de 
coherencia óptica (OCTA) son herramientas útiles, 
capaces de localizar los plexos capilares afectados 
en esta retinopatía infecciosa. Aunque infrecuen-
tes (respecto del total de pacientes infectados) las 
manifestaciones neurooftalmológicas son causa 
de consulta oftalmológica por síntomas visuales 
e interconsultas de pacientes hospitalizados. Los 
tratamientos disponibles incluyen medidas de so-
porte y asistencia general, corticoides sistémicos 
y tratamiento con inmunoglobulina intravenosa. 
Existe una urgente necesidad de ensayos clínicos 
orientados a testear drogas con conocida actividad 
estabilizadora de la permeabilidad vascular retinal 
así también como de drogas antivirales.
Palabras clave: dengue, infecciones oculares.
Manifestações inflamatórias oculares 
induzidas pelo vírus do dengue
Resumo
A infeção por dengue produz um amplo espectro 
de manifestações inflamatórias oculares. As que 
acontecem durante o período crítico da doença 
estão associadas com dano vascular induzido pela 
proteína viral NS1. As manifestações retinianas 
que põem em risco a visão do paciente durante esse 
período são as uveítes posteriores e a maculopatia 
por dengue. Hemorragias, edema e vasculite reti-
niana junto com o desprendimento exudativo de 
retina são as manifestações oculares mais frequen-
tes da uveíte posterior. A tomografia de coerência 
óptica de domínio espectral (SD-OCT) e a angio-
grafia tomográfica de coerência óptica (OCTA) são 
ferramentas úteis, capazes de localizar os plexos 
capilares afetados nesta retinopatia infeciosa. Em-
bora infrequentes (em relação ao total de pacientes 
infetados) as manifestações neurooftalmológicas 
são causa de consulta oftalmológica por sintomas 
visuais e interconsultas de pacientes hospitaliza-
dos. Os tratamentos disponíveis incluem medidas 
de suporte e assistência geral, corticoides sistêmi-
cos e tratamento com imunoglobulina intravenosa. 
Existe uma urgente necessidade de ensaios clínicos 
orientados a testar drogas com conhecida ativida-
de estabilizadora da permeabilidade vascular reti-
niana como também de drogas antivirais.
Palavras chave: dengue, infeções oculares.
Introduction
Dengue virus (DENV) belongs to the 
Flaviviridae virus family. It is an arbovirus, an 
arthropod borne virus1, meaning that the virus 
is transmitted by an arthropod. 
The mosquito Aedes aegypti is its main vector 
in urban settings and Aedes albopictus in rural 
and rainforest areas. The recent expansion of 
Aedes aegypti distribution in the world resulted 
in a 30 fold increase in the incidence of dengue 
disease in the last decades2-3.
DENVs are a group of positive mono-catenary 
RNA viruses that are antigenically related and 
grouped according to the human serum response 
(serotype) in DENV-1 to DENV-4. The genome 
is an 11 Kb RNA strand with 10 genes coding 3 
structural proteins and 7 nonstructural proteins. 
Protein M and Protein E are the main proteins 
of the envelope. Protein C forms the capsid. The 
nonstructural proteins are NS1, NS2A, NS2B, 
NS3, NS4A, NS4B and NS51.
Dengue is found in tropical and sub-trop-
ical climates worldwide, mostly in urban and 
semi-urban areas. The global incidence of den-
gue has grown dramatically in recent decades. 
There are 100-400 million of estimated infections 
each year. The largest number of dengue cases 
ever reported globally was in 2019. The American 
region alone reported 3.1 million cases, with more 
than 25,000 classified as severe2. According to the 
National Health Ministry, Argentina has more 
than 92.229 dengue suspected cases since week 
31 of 2019 (end of July 2019)4. Of those patients, 
56492 are confirmed dengue cases. The propaga-
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tion of the disease from the north of the country 
during the first trimester of 2020, resulted in the 
worst known epidemy of dengue in Argentina. 
Current prevalent serotypes in Argentina are 
DENV-1 in the northwest, DENV1- and DENV-4 
in the center and DENV-1, DEN-2 and DENV-4 
in the northeast of the country. The three sero-
types (DENV-1, DENV-2 and DENV-4) were also 
detected in Buenos Aires province4.
Each serotype comprises several genotypes 
that have specific geographical distributions5. 
Five genotypes for DENV-1, 6 for DEN-2, 5 for 
DENV-3 and 4 genotypes for DNV-4. Infection 
by any of the serotypes generates a humoral 
immune response. Antibodies providing protec-
tion against all serotypes are called heterotypic 
antibodies and their protection lasts approxi-
mately 3 months. Specific antibodies against the 
infective serotype (homotypic antibodies) provide 
homotypic protection which was believed to be 
lifelong6. However, in a recent review of samples 
from patients in Nicaragua (obtained between 
epidemic outbreaks 2005 to 2012) homotypic 
reinfections were found within the same sero-
type for DENV-1, DENV-2 and DENV-3 sero-
types7. Analysis of samples from patients rein-
fected in a large outbreak in Peru 2010-2011 also 
showed homotypic reinfection of patients with 
a DENV-2 American-Asian genotype different 
from the infecting DENV-2 Asian genotype that 
primarily infected the patients in 19958. Together 
the data destroyed the dogma: one-time infection 
by a homologous DENV serotype.
Pathophysiology
The DENV NS1 protein is a complex multi-
function protein involved in capsid assembly, 
host immune system evasion and vascular leak-
age. DENV NS1 has been shown to circulate as 
a soluble protein at high levels (1-2 μg/ml), cor-
relating with DENV viremia9.
The hallmark of severe dengue is increased 
vascular permeability. Collapse of the vascu-
lar lumen as well as increase endothelial mark-
ers were shown in small vessels while no signs 
of endothelial cell (EC) necrosis or EC DENV 
infection accompanied the above mentioned 
changes10. Vessel hyperpermeability was sug-
gested to be either a direct effect of DENV NS1 
on the glycocalyx11 or a consequence of the func-
tion of several cytokines released by PBMC12 after 
the activation of Toll-like-receptor-4 TLR413. It 
was shown that DENV-NS1 can activate siali-
dases, cathepsin L and heparinases thus trigger-
ing the degradation of sialic acid and heparan 
sulfate at the glycocalyx14. DENV NS1 was shown 
to induce hyperpermeability in all tested human 
endothelial cells, with maximal effect on pulmo-
nary endothelial cells15. The vascular leakage is 
apparently mediated by the specific interaction 
and subsequent internalization of NS1 in endo-
thelial cells. Recently, the decrease of EC barrier 
integrity was associated with the activation of the 
p38MAPK pathway and it could be restored after 
the treatment with a p38MAPK inhibitor16.
Humoral immune response
Antibodies typically protect humans from 
viruses in 3 ways: A) neutralization (antibody 
blocks virus interaction with host cell), B) 
opsonization (antibody coats virus and typically 
targets it for uptake by macrophages and neutro-
phils), C) antibody-dependent cellular cytotox-
icity (ADCC, where the antibody mediates the 
destruction of infected cells).
In severe dengue, antibodies play a different 
detrimental function for the host. Severe den-
gue most commonly occurs among patients with 
secondary DENV infections and infants with pri-
mary infections. The most widely cited hypoth-
esis for the pathogenesis of severe dengue in a 
second infection setting is called antibody-depen-
dent enhancement (ADE)17. Human serological 
studies, as well as animal and in vitro models 
support the ADE hypothesis. Although the exact 
mechanisms are not clear, ADE is the process 
in which DENV complexed with non-neutral-
izing antibodies can enter into a greater propor-
tion of cells of the mononuclear lineage, such 
as monocytes, macrophages and dendritic cells, 
thus increasing the quantity of infected cells and 
consequently increasing virus production. In 
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dengue, non-neutralizing heterotypic IgG anti-
DENV antibodies produced during first DENV 
infection can form antibody-DENV complexes 
in the second infection that can allow uptake of 
DENV by mononuclear cells. DENV then rep-
licates in these macrophages thereby increasing 
viral production. The uptake of the heterotypic 
antibody-virion complex occurs after the docking 
of the immune complex to the Fcγ-R of a mono-
nuclear cell expressed on its surface18. Recently, 
dengue viral load at presentation and the odds 
of severe disease were highest among patients 
with low to intermediate pre-infection antibody 
titers and lowest among those with the highest 
antibody titers19.
The role of antibodies against NS1 is still matter 
of discussion. On the one hand, passive transfer of 
anti-DENV-NS1 antibodies to mice has proven to 
avoid lethal encephalitis20. Antibodies that bind 
sNS1 in circulation were shown to neutralise its 
vasoactive effects, as demonstrated in a mouse 
model of NS1-induced vascular leakage12. On the 
other hand, human antibodies against NS1 may 
react against human endothelial cells21, platelet 
antigens22 and anticoagulation factors23. Human 
antibodies against NS1 can also consequently 
produce vascular leakage, thrombocytopenia and 
coagulopathy, possibly as a consequence of NS1 
mimicry effect.
Clinical symptoms
In 2009, the WHO changed the definition of 
dengue infection. Symptomatic dengue can pres-
ent as undifferentiated fever, dengue and severe 
dengue. Asymptomatic dengue could represent 
at least approximately 10% of infected patients24. 
The main symptom in dengue is fever, usually 
higher than 38°C, reaching in many patients 40°C 
and lasting 3-7 days. Myalgia, joint pain, retrooc-
ular pain, sore throat and facial erythema could 
also be present. Dengue can present with alarm-
ing signs: abdominal pain, persistent vomiting, 
clinically evident fluid accumulation, mucosal 
bleeding, lethargy or restlessness, liver enlarge-
ment > 2 cm, increased hemoconcentration con-
current with platelet decline25. Alarming signs 
indicate the need for patient hospitalization to 
avoid severe complications. Severe dengue can 
present as severe plasma leakage, severe bleeding 
or severe organ involvement25.
After the mosquito bite there is a period 
of up to 7 days of incubation without clinical 
symptoms. The febrile period lasts between 4-7 
days and is followed by the critical period. This 
period lasts approximately 2 days and is char-
acterized by defervescence (decrease in body 
temperature), hemoconcentration and decrease 
of platelet count. The recovery phase is the last 
period and is characterized by the return of 
plasma to the vasculature with near normal 
hematocrit values.
Diagnosis of dengue infection
Approximately 24 to 48 h before the febrile 
period there is already detectable viremia which 
lasts till the start of the critical period. During 
viremia either RNA or antigen detection meth-
ods could be used for the diagnosis of Dengue 
infection. The CDC and the WHO recommend 
RT-PCR for the diagnosis of dengue disease, 
during this period. After the febrile period, the 
diagnosis is based on the detection of specific 
IgM and IgG antibodies1, 25.
Ocular manifestations of dengue
Anterior manifestations
Subconjunctival hemorrhages are the most 
frequent ocular sign reported by patients with 
dengue infection. Up to 37,3% of patients with 
thrombocytopenia presented it during the criti-
cal period26. Diffuse epithelial keratitis as well as 
stromal keratitis has been reported in patients 
with acute dengue infection27. Necrotizing scleri-
tis was observed in a Japanese patient without 
precedent autoimmune diseases who became 
infected with dengue virus during holidays in 
the Philippines28. The patient’s scleritis was con-
trolled with methylprednisolone pulse-therapy. 
There were no further recurrences after treat-
ment, but the patient developed scleral thinning 
over the following years.
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Other anterior manifestation of dengue infec-
tion is acute angle closure glaucoma (AAG). 
AAG associated with dengue can present with 
unilateral or bilateral involvement29. This entity 
may be associated with extensive choroidal effu-
sions30 or as a consequence of an iris plateau 
configuration31.
Patients presenting with ocular pain, eye red-
ness and photophobia few weeks or months after 
acute dengue fever are frequently diagnosed with 
presumed dengue associated anterior uveitis32. 
Anterior uveitis (AU) is less frequently diag-
nosed during acute disease33. AU can present as 
unilateral or bilateral uveitis, more frequently 
as non-granulomatous uveitis34. The etiological 
mechanism seems to be an autoimmune reac-
tion following dengue infection since the patients 
respond to topical or periocular corticosteroids.
Posterior manifestations
Intermediate uveitis is an infrequent presen-
tation of dengue infection. In a series of 65 eyes 
of patients with visual complains associated with 
dengue infection only 8 had intermediate uve-
itis35. Approximately 11% of patients who expe-
rience dengue maculopathy, a frequent clinical 
presentation of dengue infection, also have signs 
of intermediate uveitis36.
Posterior uveitis (PU) is a common complica-
tion of dengue infection. PU by dengue is one of 
the three more frequent aetiologies of posterior 
uveitis in Singapore37. Clinical presentations of PU 
in dengue comprise vascular retinitis, exudative 
retinal detachment, chorioretinitis and neuroreti-
nitis (Table 1). In a study that included 41 patients, 
15 of 65 eyes with posterior ocular manifestations 
had retinal vasculitis38. Other retinal signs associ-
ated with retinal vasculitis are intraretinal hem-
orrhages and exudative retinal detachment39-40. 
Exudative retinal detachment was observed in 
13 of those 15 previously mentioned eyes with 
severe retinal vasculitis in the study published by 
Theo SC. In severe cases of retinal vasculitis reti-
nal ischemia may be present due to microvascular 
occlusion41. When the macular retinal detachment 
has fibrinous material a pseudophypopion can be 
observed as that reported in two patients from 
Malaysia42.
Multifocal areas of chorioretinitis with retinal 
vasculitis, retinal hemorrhages and exudates were 
described by Tabbara K in 2 patients from Saudi 
Arabia43.The patients had leukopenia and throm-
Table 1. Uveitis caused by dengue virus infection. Clinical presentations reported frequencies and response to treatment.
Uveitis Clinical presentation Frequency Response to treatment
Anterior Unilateral or bilateralPredominantly non-granulomatous
Frequent after the recovery period, up to 5 
months Good response to topical corticosteroids
Intermediate Associated with dengue maculopathy Rare Insufficient data
Posterior
Retinal vasculitis Frequent
Good response to systemic corticosteroids
Final visual acuity varies according to lesion 
in the outer retinal layers
Exudative retinal detachment Frequent
Multifocal chorioretinitis
Less frequent
Acute posterior multifocal placoid pigment 
epitheliopathy (APMPPE)
Choroiditis
Acute zonal occult outer retinopathy (AZOOR)
Neuroretinitis (macular star) Rare
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bocytopenia with high titers of IgM anti-den-
gue. The healing of the lesions left discrete atro-
phic chorioretinal scars with nummular shapes. 
Chorioretinal lesions during dengue infection 
may display features in the spectrum of acute 
posterior multifocal placoid pigment epitheli-
opathy (APMPPE)44 or choroiditis45. Multifocal 
chorioretinal lesions resembling APMPPE were 
described in a patient who developed dengue 
fever after visiting the Caribbean islands. The 
OCT revealed disruption of the ellipsoid layers 
and RPE. The healing of the lesion left discrete 
chorioretinal scars44. Severe decrease in visual 
acuity and persistent scotoma in patients with 
dengue infection were associated with disruption 
of the outer neurosensory retina involving the 
outer limiting membrane, the myoid and ellipsoid 
zone as well as the outer segments of the photo-
receptors, findings similar to those described in 
acute zonal occult outer retinopathy, AZOOR46-47.
Concomitant inflammation of the optic nerve 
and macula can manifest as neuroretinitis. A classi-
cal presentation of neuroretinitis with vitritis, papil-
litis, exudates forming a macular star was reported 
in a Brazilian patient with acute dengue fever48.
Two reports of blinding panophthalmitis 
in patients with severe dengue were recently 
described49-50. In both cases, the patients were 
admitted to hospital. They developed panoph-
thalmitis due to secondary bacterial infec-
tion (Staphylococcus epidermidis and Bacillus 
Cereus). Both patients survived but the infected 
eyes were eviscerated.
Clinical spectrum of dengue maculopathy
Dengue maculopathy is the most frequent 
cause of visual complains in patients with dengue 
infection. Approximately 10% of infected patients 
admitted to hospitals will develop dengue mac-
ulopathy (DM)51 or complain of blurry vision52. 
Main visual symptoms are blurry vision and or 
scotomata51. Decrease of visual acuity (VA) typ-
ically appears during the critical period, but it 
can also present up to 30 days after the febrile 
period. Other less frequent symptoms are myo-
desopsia and metamorphopsia. The decrease in 
VA at the time of diagnosis is mild to moderate 
in most patients. Approximately 69% of patients 
had a VA of 20/200 or better according to Teoh 
et al35. Bilateral involvement is very frequent but 
usually asymmetrical35-36. The triad of photopsia, 
myodesopsia and blurry vision was highly pre-
dictive of retinal hemorrhages52.
According to its pathogenesis and ordered by 
frequency: macular edema, macular retinal detach-
ment + severe vasculitis, macular hemorrhage and 
foveolitis are the most frequent clinical presenta-
tions of DM42. In a small case series, Chan et al 
found that macular hemorrhages were the most fre-
quent cause of decreased visual acuity followed by 
retinal vasculitis and macular retinal detachment33.
Three different patterns were described in 
DM using standard optical coherence tomogra-
phy (OCT): diffuse retinal edema, cystoid retinal 
edema and foveolitis (Table 2). The latter is char-
acterized by a thickening and hyperreflectivity of 
the subfoveal outer retinal layers38.
The use of OCT angiography (OCTA) in patients 
with foveolitis and outer maculopathy shows flow 
deficit of the superficial retinal capillary plexus in 
43,75% of the patients. Areas with flow deficit in 
the deep retinal capillary plexus were present in 
all patients. None of the eyes showed presence of 
choriocapillaris flow deficit areas53.
Recently a new clinical presentation involving 
the macular neuroretina during dengue disease 
was described. Acute macular neuroretinopathy 
(AMN) is characterized by ischemia of the retinal 
deep capillary plexus (DCP)54. Clinically, retinal 
exudation can present around the foveal area. 
Macular retinopathy can be accompanied by vitri-
tis and by optic nerve inflammation. Fluorescein 
angiography may show vascular leakage in the 
macular area and optic disc staining in the late 
phase. The OCTA displays involvement of the 
different vascular retinal plexus but only the deep 
retinal capillary plexus are associated with the 
disruption of the IS/OS junction of the retina, a 
typical finding in optical coherence tomography 
(OCT) of AMN patients55.
Other reported immediately after macular com-
plication dengue infection is choroidal neovascular-
ization56. Veloso et al described the case of a 54-year-
old female patient complaining of decreased visual 
acuity in her left eye two weeks after dengue fever. 
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A diagnosis of classic CNV was made with FA and 
confirmed with SD-OCT. The patient was treated 
with ranibizumab intravitreal injections reaching a 
BCVA of 20/20 after the treatment.
Neuro-ophthalmological manifestations
Approximately 97% of patients with dengue 
fever will complain of headaches57. Neurological 
signs upon dengue infection are reported in 
only 1% to 5% of patients58 and neuro-oph-
thalmic manifestations are rare or infrequent59. 
Nevertheless, in the clinical history of 2 out of 
the 3 patients described below, who sought oph-
thalmic consultation during the 2020 epidemic in 
Misiones, the primary ocular manifestation was 
neuro ophthalmological. Encephalitis and dengue 
encephalopathy are the most frequent neurolog-
ical manifestations, followed by Guillain-Barré 
syndrome and nerve palsies. Abducens nerve 
palsies (VI nerve palsy) is a frequent form of 
nerve palsies associated with dengue infection. 
Abducens palsies as well as the above mentioned 
neurological manifestations are more frequent 
during the critical period60-62. Optic neuritis was 
reported to occur in 0.1% to 1.5% of patients 
with dengue infection35. It could present as either 
inflammation of the optic disc or as retrobulbar 
optic neuritis63-64. Recently, Lana-Peixoto et al 
reported two cases of neuromyelitis optica spec-
trum disorder (NMOSD) in patients positive for 
serum AQP4-antibody suggesting that dengue 
infection may trigger seropositive NMOSD65.
Treatment
Good resolution of anterior mild inflammatory 
manifestations may be achieved with topical cor-
ticosteroids such as in mild to moderate anterior 
uveitis66. Local periocular treatment (sub-Tenon’s 
triamcinolone injection) can be used in severe 
forms of unilateral anterior uveitis and mild cases 
of dengue retinopathy. The use of intravitreal tri-
amcinolone can be considered in patients with 
unilateral maculopathy36.
Table 2. Dengue maculopathy: clinical presentations and findings on fluorescein angiography (FA), optical coherence 
tomography (OCT) and OCT-angiography (OCTA).
Dengue maculopathy Clinical presentation Fluorescein-angiography (FA) OCT pattern OCT-A pattern
Macular edema
Diffuse macular edema Late hyper-fluorescence. Diffuse fluorescein leakage
Diffuse retinal thickening 
(DRT), around central/ 
paracentral fovea. Loss of 
foveal dimple Flow deficit in the superficial 
capillary plexus
Cystoid macular edema
Hyper-fluorescence due to 
leakage in cystoid retinal 
spaces in middle and late 
stages
Cystoid fluid spaces in the 
middle layers of the retina
Exudative retinal 






fluorescence in middle and 
late stages
Subretinal fluid, cystoid 
macular edema may also be 
present
Not described for dengue
Macular hemorrhage Macular hemorrhage
Hypo-fluorescence due to 
fluorescence blocking in the 
macular area
Accumulation of fluid of 
medium reflectivity at the 
retina affecting the normal 
layers architecture
Not described for dengue
Foveolitis
White yellowish dots in the 
fovea
Mild vitritis
Perivascular foveal leakage 
and blockage of arteriolar 
fluorescence
Hyper-reflectivity at the 
outer plexiform and outer 
nuclear layers
Flow deficit in the superficial 
and deep capillary plexus
Acute macular 
neuroretinopathy (AMN)
Exhudation around vessels 
of macular area
Fluorescein vascular leakage 
around the macular vessels. 
Optic disc staining in late 
phase
Disruption of the IS/OS 
junction in the outer retina
Flow deficit in the 3 capillary 
plexus, low VA is associated 
with flow deficit of the deep 
capillary plexus
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Systemics corticosteroids are needed in severe 
scleritis and in posterior manifestations where 
immune mediated mechanisms are suspected (ret-
inal vasculitis, AMN and foveolitis). In patients 
whose visual acuity was lower than 20/100, meth-
ylprednisolone pulse therapy (1 g/day) was effi-
cient in the treatment of severe posterior uveitis 
and optic neuritis. Pulse therapy should be fol-
lowed by oral prednisone with slow tapering.
There are few reports of severe PU and den-
gue maculopathy patients with VA lower than 0.1 
treated with intravenous Immunoglobulin (0,4 g/
kg/ day) for 3 days. Visual acuity was restored to 
0.5 after 15 days of treatment67.
Despite the fact that anti-VEGF therapy had 
shown to restore vascular permeability in mac-
ular edema associated with retinal vasculopathy, 
there are no reports regarding its use in dengue 
maculopathy except for choroidal neovascular-
ization56. The use of such well-known agents 
could be hypothetically useful, specially in mac-
ular edema caused by dengue infection.
Ocular findings in patients examined 
during the 2020 dengue epidemic
Case 1 (retroorbital pain-normal vision)
A 42 years old man seeks consultation due to 
retroocular pain. He has been diagnosed dengue 
fever by a medical doctor specialized in tropical 
medicine. He suffered high fever, asthenia and 
myalgia for 5 days. He is in the recovery phase 
but still complains of bilateral retroocular pain. 
A diagnosis of dengue is suspected based on the 
symptoms and a positive antigen NS1 ELISA 
test. His best corrected visual acuity (BCVA) 
was 20/20 in both eyes. The patient had normal 
pupillary reflexes and ocular movements. There 
were no anterior signs of ocular inflammation. 
Intraocular pressure was 16 mmHg in both eyes. 
There were scattered retinal hemorrhages outside 
the posterior pole in both eyes (Fig. 1). A small, 
yellow, well-defined deep retinal dot like those 
described in foveolitis was observed in the supe-
rior part of the macula, outside the fovea, in the 
right eye (Fig. 1). The patient received no treat-
ment and was controlled 15 days later dengue dis-
ease was confirmed by the presence of anti DENV 
positive IgM and IgG results. Resolution of the 
hemorrhages and the macular spot was con-
firmed after 3 months of the initial examination.
Case 2 (severe unilateral decrease in visual acuity)
A 38-year-old male patient seeks ophthalmic 
consultation as an outpatient in a private clinic. 
He complains of decrease in visual acuity in the left 
eye for the last 3 days accompanied by pain when 
moving the eye. Three weeks before he had 4-day 
episode of fever, malaise and headaches. He also 
Figure 1. (A) Small yellowish retinal lesion in the inferior area of the macula outside the fovea (arrow). (B) Retinal hemorrhage in the nasal area of the 
right eye (arrow).
A B
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referred a history of relatives with dengue infection. 
BCVA was 20/20 in the right eye and counting fin-
gers on the left eye. There was a RAPD in the left 
eye and severe decrease in the chromatic vision. 
The anterior biomicroscopy was normal as well as 
the intraocular pressure in both eyes. The fundus 
of the eye revealed a left optic disc with diffuse bor-
ders and inflammation (Fig. 2). There were no signs 
of retinopathy. The right eye fundus was normal. 
Routine lab exams (hematocrit, ESD, kidney and 
liver function assays) as well as an MRI with gado-
linium of the CNS and serology for dengue, syphilis 
and toxoplasma gondii were ordered. The patient 
did not want to receive corticosteroid pulsetherapy 
in a hospital, due to the COVID-19 pandemic, so 
he started oral meprednisone 1mg/kg/day as an 
outpatient. The CNS MRI results, and the routine 
lab exams were normal. VDRL and serology for 
syphilis were negative. A positive IgM and IgG 
anti-DENV was detected. Serology for toxoplasma 
gondii indicated a chronic infection, a regular find-
ing in an adult patient from Misiones. The patient 
visual acuity started to improve daily. After 4 weeks 
of treatment the patient attained 20/20 vision on 
the left eye and his visual fields were normal.
Case 3 (abducens nerve palsies)
A 42 years old man seek consultation at the 
emergency room. He complained of dysesthesia 
in his lower extremities, dysarthria and diplopia 
for the last 48 h. He had fever, myalgia and gas-
trointestinal symptoms for the last 10 days. He 
explains that due to the SARS-Cov2 pandemic 
intercurrence he received telephonic assessment 
and was prescribed paracetamol. The clinician 
that examined him in the emergency room 
ordered routine blood laboratory test (hematocrit, 
WBC count, ESR, PCR, liver and kidney function 
laboratory tests), a Central Nervous System CAT-
scan without gadolinium and an ophthalmologic 
examination. The CNS CAT-scan was normal. 
The ophthalmic examination revealed: BCVA 
of 20/20 in both eyes and a 30-degree esotropia 
in the left eye. Limited abduction of the left eye 
was confirmed and a left abducens nerve palsy 
was diagnosed. Due to his poor general health 
status (fever, tremors and asthenia) the patient 
was admitted to the hospital. A fundus examina-
tion showed performed revealing retinal exudates 
along the temporal vessel in the right eye and a 
small macular hemorrhage in the left eye. The 
neurologists that examined the patient ordered 
a CNS MRI with gadolinium and an angio-MRI. 
The exams revealed an acute ischemic event at 
the knee of the corpus callosum and also in the 
left cerebellum (Fig. 3). Due to the patient’s signs 
and symptoms and the SARS-Cov-2 pandemic + 
dengue epidemic intercurrence, the patient was 
isolated and nasopharyngeal and blood sam-
ples were obtained. Seventy-two hours later the 
Figure 2. Images of the right and left posterior fundus of the eye. The right optic disc and macular area appears normal. The left optic disc has diffused 
borders with exudative changes that together with the clinical presentation of the patient led to the diagnosis of left optic neuritis.
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SARS-Cov-2 PCR result was negative and the 
NS1 for dengue was positive. No specific treat-
ment was administered during the days of hos-
pital admission. The neurological symptoms and 
ocular motor paresis improved without specific 
treatment. The diagnosis of dengue disease was 
confirmed with IgM and IgG positive serology. 
A diagnosis of reversible splenial syndrome 
(RESLES) was made based on signs and symp-
toms manifested by the patient, MRI images and 
the evolution of the patient. Although RESLES 
was recently described in a patient with dengue 
infection, this is the first case were RESLES is 
described with angiopathic changes in the retina.
Discussion
The ocular clinical spectrum caused by dengue 
infection is not random. It is influenced by the 
degree of vascular endothelial damage induced 
by the virus as well as the inflammation induced 
by the immune response of the host. A predom-
inance of retinal hemorrhages and perivascular 
exudates in the fundus examination are an indic-
ative of endothelial cell damage, the presence of 
retinal vasculitis and optic neuritis are more likely 
associated with a significative humoral immune 
response. Mechanistically it seems that early in 
the evolution of the disease (symptomatic and 
critical period), ocular and neuro-ophthalmo-
logical manifestations may be related to direct 
viral effects, immune mediated or due to sys-
temic or metabolic complications (thrombocy-
topenia, leukopenia or hypoalbuminemia), while 
post-recovery and late manifestations are mainly 
immune mediated.
The posterior exudative and hemorrhagic 
manifestations are also influenced by the depth 
of the retinal capillary plexus disrupted. The more 
superficial the retinal capillary plexus affected 
the more superficial the exudation in the retina, 
resembling Purtscher-like retinopathy68. On the 
other hand, posterior deep manifestations such 
as foveolitis or AMN indicate the involvement 
of deep retinal capillary plexus. Knowledge of 
the retinal plexus involved is important because 
the alteration of deep retinal plexus is associated 
with disruption of the ellipsoid and interdigita-
tion zone of the outer retina and a consequent 
Figure 3. Central Nervous System MRI with gadolinium showing lesion in the central splenium of the corpus callosum in the diffusion-weighted imaging 
(image on the right). After two weeks the lesion in the corpus callosum disappeared (image on the left).
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persistent decreased visual acuity and scotoma as 
described in AMN55. Together, the results indicate 
a relevant role of OCTA in the diagnosis of the 
retinopathy upon dengue infection.
Endothelial damage and vascular leakage are 
the main pathogenetic mechanism during the 
first two weeks of the disease while immunologi-
cal mechanism may persist for few months. After 
an extensive search in the online clinical data-
bases only one publication of chronic uveitis was 
associated with dengue infection. Recently, how-
ever, in a population based cohort study dengue 
infection was associated with the development 
of a higher frequency of autoimmune diseases. 
The list of diseases included known etiology for 
anterior uveitis (Reiter’s syndrome) and posterior 
or diffuse uveitis (systemic vasculitis) as well as 
optic neuritis (multiple sclerosis)69.
Despite our limited experience with the dis-
ease, the review of dengue epidemics, including 
the 2020 dengue epidemic in Misiones, taught 
us valuable lessons: 1) patients with dengue 
infection may be visually asymptomatic but still 
present retinal changes, while the disease is not 
affecting the fovea. Also, afebrile or asymptom-
atic dengue infected patients may develop exu-
dative or inflammatory ocular manifestations, so 
dengue infection should be ruled-out if clinical 
ocular signs are compatible with dengue diag-
nosis. 2) The use of new technologies such as 
SD-OCT and OCTA can help in the diagnosis 
of the retinopathy and follow up of patients. 3) 
Neuro-ophthalmological signs may not be that 
infrequent as described. Two out of the 3 patients 
that seek ophthalmologic examination and were 
examined by the authors, had neuro-ophthalmo-
logical manifestations. 4) Immune mediated ocu-
lar manifestations such as anterior uveitis, reti-
nal vasculitis and optic neuritis may appear few 
weeks or months later after the critical period of 
the disease. 5) The treatment of posterior uve-
itis and dengue maculopathy has been limited to 
corticosteroids and intravenous immunoglobu-
lin. Clinical studies using agents known to restore 
vascular permeability such as bevacizumab, ran-
ibizumab and aflibercept can be projected to eval-
uate its clinical use in dengue maculopathy as 
additional treatments.
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